N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). (Q34360861)

1 August 2017

0 references

N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). (English)

1 reference

1 August 2017

Michael H Baumann

1

1 reference

1 August 2017

Robert D Clark

2

1 reference

1 August 2017

Allison G Budzynski

3

1 reference

1 August 2017

John S Partilla

4

1 reference

1 August 2017

Bruce E Blough

5

1 reference

1 August 2017

Richard B Rothman

6

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

1 August 2017

published in

Neuropsychopharmacology

1 reference

1 August 2017

volume

30

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

550-560

1 reference

TFMPP and RU24969 enhance serotonin release from rat hippocampus

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Pharmacological studies of the acute effects of (+)-3,4-methylenedioxymethamphetamine on locomotor activity: role of 5-HT(1B/1D) and 5-HT(2) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin(2C) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Functional correlates of serotonin 5-HT1 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Stimulus properties of antidepressants in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

MDMA: A Review of Epidemiological Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Chemistry, Pharmacology, Toxicology, and Hepatic Metabolism of Designer Drugs of the Amphetamine (Ecstasy), Piperazine, and Pyrrolidinophenone Types

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Ecstasy (MDMA): a review of its possible persistent psychological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Serotonin-releasing effects of substituted piperazines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Therapeutic and adverse actions of serotonin transporter substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Mazindol attenuates the 3,4-methylenedioxymethamphetamine-induced formation of hydroxyl radicals and long-term depletion of serotonin in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

A2 (N-benzylpiperazine) a new drug of abuse in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

7 January 2021

Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

7 January 2021

Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

7 January 2021

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

7 January 2021

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

7 January 2021

Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300585

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300585

1 reference

Dimensions Publication ID

1 August 2017

1018441766

0 references

1 reference